|
Index of reports
> Cases with Thirst (5)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ludiomil (Maprotiline) where reactions include thirst. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Ludiomil side effects in female
Reported by a pharmacist from Japan on 2012-04-02
Patient: female, weighing 42.0 kg (92.4 pounds)
Reactions: Wrist Fracture, Drug Interaction, Thirst, Hallucination, Fall
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Comtan
Dosage: 500 mg
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-12-20
Ludiomil
Dosage: 10 mg
Administration route: Oral
Indication: Depression
Start date: 2011-10-21
Neodopasol
Dosage: 500 mg
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-10-21
Pramipexole Dihydrochloride
Dosage: 0.125 mg
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-10-21
End date: 2011-12-22
Other drugs received by patient: Aricept; Magmitt; Loxonin; Depas; Motilium; Lansoprazole; LAC-B; Selbex
Possible Ludiomil side effects in male
Reported by a physician from Germany on 2012-03-16
Patient: male
Reactions: Confusional State, Restlessness, Hyponatraemia, Thirst, Intentional Self-Injury, Pallor, Delirium, Somnolence, Suicide Attempt, Inappropriate Antidiuretic Hormone Secretion, Depressed Mood, Cold Sweat, Tension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Anafranil
Administration route: Oral
Indication: Depression
Start date: 2011-11-15
End date: 2012-01-26
Ludiomil
Administration route: Oral
Indication: Depression
Start date: 2011-11-15
End date: 2012-01-26
Risperdal
Administration route: Oral
Indication: Delusion
Start date: 2012-01-26
End date: 2012-01-26
Risperdal
Administration route: Oral
Start date: 2012-01-19
Risperdal
Administration route: Oral
Indication: Depressive Delusion
Start date: 2012-01-26
End date: 2012-01-26
Risperdal
Administration route: Oral
Start date: 2012-01-19
Other drugs received by patient: Seroquel; Seroquel; Seroquel; Lorazepam
Possible Ludiomil side effects in female
Reported by a pharmacist from Japan on 2012-03-08
Patient: female, weighing 42.0 kg (92.4 pounds)
Reactions: Nightmare, Wrist Fracture, Saliva Altered, Thirst, Hallucination
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ludiomil
Administration route: Oral
Indication: Depression
Start date: 2011-12-20
Neodopasol (Levodopa_benserazide Hydrochloride)
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-12-20
Pramipexole Dihydrochloride
Dosage: 0.125 mg
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-12-20
Other drugs received by patient: Comtan; Selbex; Motilium; Magmitt; Depas; Lansoprazole; LAC-B; Aricept; Loxonin
Possible Ludiomil side effects in female
Reported by a pharmacist from Japan on 2012-02-29
Patient: female, weighing 42.0 kg (92.4 pounds)
Reactions: Nightmare, Wrist Fracture, Saliva Altered, Thirst, Hallucination
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ludiomil
Administration route: Oral
Indication: Depression
Start date: 2011-12-20
Neodopasol (Levodopa_benserazide Hydrochloride)
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-12-20
Pramipexole Dihydrochloride
Dosage: 0.125 mg
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-12-20
Other drugs received by patient: Comtan; LAC-B; Lansoprazole; Loxonin; Selbex; Aricept; Depas; Motilium; Magmitt
Possible Ludiomil side effects in female
Reported by a pharmacist from Japan on 2012-02-28
Patient: female, weighing 42.0 kg (92.4 pounds)
Reactions: Nightmare, Wrist Fracture, Saliva Altered, Thirst, Hallucination
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ludiomil
Administration route: Oral
Indication: Depression
Start date: 2011-12-20
Neodopasol
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-12-20
Pramipexole Dihydrochloride
Dosage: 0.125 mg
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-12-20
Other drugs received by patient: Loxonin; Aricept; Lansoprazole; Motilium; Comtan; LAC-B; Magmitt; Depas; Selbex
|
